[1]
“Baricitinib for hospitalised COVID-19 patients: was it a good and timely decision made by the Ministry of Health Malaysia? High-quality evidence-based editorial”, Int. Med. Res. J., vol. 10, no. 1, Sep. 2026, Accessed: Oct. 23, 2026. Available: https://journal.nih.gov.my/index.php/imrj/article/view/157